Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.
主要な著者: | MacMahon, S, Rodgers, A, Collins, R, Farrell, B |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1994
|
類似資料
-
ANTIPLATELET THERAPY TO PREVENT THROMBOSIS AFTER HIP FRACTURE - REPLY
著者:: Macmahon, S, 等
出版事項: (1995) -
The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
著者:: Prentice, C, 等
出版事項: (1999) -
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
著者:: Kyung Won Kim, 等
出版事項: (2021-01-01) -
Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
著者:: Collins, R, 等
出版事項: (1994) -
A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial
著者:: de Haan RJ, 等
出版事項: (2010-05-01)